Dolphin K 75 mg 3 ml 3 ampoules

Dolphin K 75 mg 3 ml 3 ampoules

Composition:
Each 3 ml of solution contains:
Diclofenac potassium – 75 mg.
Excipients: Mannitol, propylene glycol, sodium bisulfite, benzyl alcohol, sodium hydroxide, water for injection.
Description:
Diclofenac potassium is a nonsteroidal anti-inflammatory drug (NSAID) with pronounced antirheumatic, analgesic, anti-inflammatory, and antipyretic properties.
Indications:
For the treatment of acute pain associated with:
Exacerbations of rheumatic conditions:
Rheumatoid arthritis, osteoarthritis, vertebral pain syndromes, ankylosing spondylitis, spondyloarthritis, extra-articular rheumatism
Renal and hepatic colic
Acute attacks of gout
Pain, swelling, and inflammation following trauma and surgical procedures
Migraine attacks.
Dosage and Administration:
For intramuscular use only. Other routes of administration are not permitted.
Inject deeply into the upper outer quadrant of the gluteal muscle.
The duration of treatment is determined by the physician.
Adults: 1 ampoule once daily.
In cases of colic or other severe pain: up to 2 injections per day (with an interval of 2 to 3 hours between doses).
Do not exceed 2 injections per day.
The maximum treatment duration is 2 days.
If continuation of therapy is required, treatment should be continued with oral tablets or rectal suppositories.
The total daily dose of diclofenac (from all forms) must not exceed 150 mg.
Contraindications:
Children and adolescents under 18 years of age
Known hypersensitivity to diclofenac potassium or any excipients, or to aspirin
Severe cardiac, hepatic, or renal insufficiency
Bradycardia, severe arterial hypotension
Gastrointestinal bleeding
Pregnancy and lactation.
Precautions:
Discontinue use if liver dysfunction develops.
Patients with cardiovascular conditions should be closely monitored during treatment.
Frail and elderly patients or those with low body weight should receive the minimum effective therapeutic dose.
Prior to initiating treatment, clinical evaluation is required in patients with:
Peptic ulcers (including history)
Intestinal bleeding (including history)
Hepatic or renal impairment (including history)
Hypertension
In patients with bronchial asthma, hay fever, acute or chronic respiratory conditions, or nasal polyps, NSAID treatment may provoke asthma attacks.
Management of such conditions is symptomatic.
Adverse Reactions:
In rare cases, injection site abscesses may occur.
Other possible adverse reactions include:
Headache, dizziness, vertigo
Tachycardia/bradycardia, hypertension, arrhythmias, heart failure
Abdominal pain, vomiting, cramps, flatulence, nausea, diarrhea, dyspepsia
Fluid retention, peripheral edema
Rash, angioedema
Local reactions at the injection site.
Storage:
Store at temperatures below 25°C, protected from light, and out of reach of children.
Packaging:
The carton contains 3 or 6 glass ampoules of 3 ml each, along with a paper package insert.